| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.34 | 5e-10 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-11 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.3 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.3 | 1e-10 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 6e-09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-15 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.26 | 0.07 |